Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
17:25:20 EDT Mon 14 Oct 2024
Enter Symbol
or Name
USA
CA



Q:TYRA - TYRA BIOSCIENCES INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
TYRA - Q0.121.95·23.039.222.02+0.080.4251.65,4331,78221.92  22.32  21.5725.14  10.4716:01:41Oct 1115 min RT 2¢

Recent Trades - Last 10 of 1782
Time ETExPriceChangeVolume
16:01:41Q22.020.08476
16:01:37Q22.020.08154
16:00:07Q22.020.08245
16:00:07Q22.020.0812
16:00:00Q22.020.08394
16:00:00Q22.020.081,200
16:00:00Q22.020.0863
16:00:00Q22.020.08152
16:00:00Q22.020.0850
16:00:00Q22.020.08117

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-10-11 08:00U:TYRANews ReleaseTyra Biosciences Announces Late-Breaking Oral Presentation on Preliminary Safety and Anti-Tumor Activity of TYRA-300 from SURF301 at the 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2024)
2024-09-11 16:05U:TYRANews ReleaseTyra Biosciences to Present at the 2024 Cantor Global Healthcare Conference
2024-09-10 16:05U:TYRANews ReleaseTyra Biosciences Appoints Doug Warner, M.D., as Chief Medical Officer
2024-08-07 16:05U:TYRANews ReleaseTyra Biosciences Reports Second Quarter 2024 Financial Results and Highlights
2024-07-02 16:05U:TYRANews ReleaseTyra Biosciences Announces Preclinical Proof-of-Concept Results with TYRA-300 in Hypochondroplasia (HCH)
2024-05-23 16:05U:TYRANews ReleaseTyra Biosciences to Present at Upcoming Investor Conferences
2024-05-09 16:05U:TYRANews ReleaseTyra Biosciences Reports First Quarter 2024 Financial Results and Highlights
2024-05-07 16:05U:TYRANews ReleaseTyra Biosciences Announces Appointments of Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. to its Board of Directors
2024-03-19 16:05U:TYRANews ReleaseTyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights
2024-02-27 16:05U:TYRANews ReleaseTyra Biosciences to Present at Upcoming Investor Conferences
2024-02-07 16:05U:TYRANews ReleaseTyra Biosciences to Present at Oppenheimer's 34th Annual Healthcare Life Sciences Conference
2024-02-02 08:00U:TYRANews ReleaseTyra Biosciences, Inc. Announces $200 Million Private Placement Financing
2024-02-01 17:30U:TYRANews ReleaseTyra Biosciences Receives FDA Rare Pediatric Disease Designation for TYRA-300 for the Treatment of Achondroplasia
2023-12-22 09:00U:TYRANews ReleaseTyra Biosciences Doses First Patient with TYRA-200 and Provides Positive Updates on TYRA-300
2023-11-08 16:05U:TYRANews ReleaseTyra Biosciences to Participate in 2023 Jefferies London Healthcare Conference
2023-11-07 16:05U:TYRANews ReleaseTyra Biosciences Reports Third Quarter 2023 Financial Results and Highlights